JIANGSU LIANHUAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 600513 for the last quarter is 683.79 M CNY, and it's 30.36% higher compared to the previous quarter. The net income of Q4 23 is 46.17 M CNY.